MELINDA VANROOYEN: Open Payments
NPI 1356536080 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 4 payments from 4 companies in 2025. Trend: 2023 $373 · 2024 $1,184 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $127 |
| GENZYME CORPORATION | 1 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $86 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $81 |
Products named: KRYSTEXXA, DUPIXENT, RELISTOR.
Industry payments across CA — which companies pay providers there.
